Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1643291
Max Phase: Preclinical
Molecular Formula: C13H12BrN3O3S
Molecular Weight: 370.23
Molecule Type: Small molecule
Associated Items:
ID: ALA1643291
Max Phase: Preclinical
Molecular Formula: C13H12BrN3O3S
Molecular Weight: 370.23
Molecule Type: Small molecule
Associated Items:
Synonyms (1): 4-({[(4'-Bromophenyl)Amino]Carbonyl}Amino)Benzenesulfonamide
Synonyms from Alternative Forms(1):
Canonical SMILES: NS(=O)(=O)c1ccc(NC(=O)Nc2ccc(Br)cc2)cc1
Standard InChI: InChI=1S/C13H12BrN3O3S/c14-9-1-3-10(4-2-9)16-13(18)17-11-5-7-12(8-6-11)21(15,19)20/h1-8H,(H2,15,19,20)(H2,16,17,18)
Standard InChI Key: DXQKMYKLTXOZRT-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 370.23 | Molecular Weight (Monoisotopic): 368.9783 | AlogP: 2.74 | #Rotatable Bonds: 3 |
Polar Surface Area: 101.29 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.19 | CX Basic pKa: | CX LogP: 2.49 | CX LogD: 2.49 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.77 | Np Likeness Score: -1.58 |
1. Pacchiano F, Carta F, Vullo D, Scozzafava A, Supuran CT.. (2011) Inhibition of β-carbonic anhydrases with ureido-substituted benzenesulfonamides., 21 (1): [PMID:21145236] [10.1016/j.bmcl.2010.11.064] |
2. Pacchiano F, Carta F, McDonald PC, Lou Y, Vullo D, Scozzafava A, Dedhar S, Supuran CT.. (2011) Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis., 54 (6): [PMID:21361354] [10.1021/jm101541x] |
3. Vullo D, Leewattanapasuk W, Mühlschlegel FA, Mastrolorenzo A, Capasso C, Supuran CT.. (2013) Carbonic anhydrase inhibitors: inhibition of the β-class enzyme from the pathogenic yeast Candida glabrata with sulfonamides, sulfamates and sulfamides., 23 (9): [PMID:23511020] [10.1016/j.bmcl.2013.02.092] |
Source(1):